News
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies to males ages 16 to 25 and is based on new data from FDA safety monitoring and a 2023 study. This includes both Pfizer's Comirnaty and Moderna's Spikevax vaccines.
Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.
The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Investor's Business Daily on MSN3d
Moderna Reverses Its Rally As It Faces Another Vaccine SetbackModerna stock toppled Wednesday after the company withdrew its application for a combination Covid and flu vaccine.
Barchart on MSN4d
Moderna Is the Largest Barchart’s Bottom 100 Stocks to Buy—But Size Alone Isn’t a Reason to InvestIt’s hard to believe Moderna (MRNA)once had a market cap exceeding $204 billion. That was in August 2021 at or near the ...
We recently published a list of These 10 Firms Just Beat the Market Today. In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback